BIXT Message Board Post 30060516 | Bioxytran Inc
home / stock / bixt / bixt message board
alicenoble32
()
Posted on: Oct/11/2023 15:05:31
Dive into the world of biotechnology with Bioxytran, Inc. ($BIXT). Their drug candidates, ProLectin-M and ProLectin-I, are set to make a difference in Covid-19, pulmonary fibrosis, and hypoxia treatment. Watch for their groundbreaking contributions to heart ischemia and stroke care. With a market cap of $25.4M+ and a previous close of 0.176, they are leading the way in healthcare innovation.
News, Short Squeeze, Breakout and More Instantly...
-
BXT-25 is expected to oxygenate the brain BOSTON, MASSACHUSETTS, June 27, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran’s...
-
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
-
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...